(Q44132225)

30 November 2017

title

Nebivolol inhibits vascular smooth muscle cell proliferation by mechanisms involving nitric oxide but not cyclic GMP. (English)

1 reference

30 November 2017

1 reference

1

Louis J Ignarro

1 reference

30 November 2017

Manisha Sisodia

2

1 reference

30 November 2017

Kim Trinh

3

1 reference

30 November 2017

Sahar Bedrood

4

1 reference

30 November 2017

Guoyao Wu

5

1 reference

30 November 2017

Liu Hua Wei

6

1 reference

30 November 2017

Georgette M Buga

7

1 reference

30 November 2017

publication date

1 September 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

7

1 reference

30 November 2017

issue

2

1 reference

30 November 2017

page(s)

83-90

1 reference

Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2802%2900113-1

7 January 2021

Nitric oxide effects on cell growth: GMP-dependent stimulation of the AP-1 transcription complex and cyclic GMP-independent slowing of cell cycling.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2802%2900113-1

7 January 2021

Nitric oxide inhibits ornithine decarboxylase via S-nitrosylation of cysteine 360 in the active site of the enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2802%2900113-1

7 January 2021

Role of p42/p44 mitogen-activated-protein kinase and p21waf1/cip1 in the regulation of vascular smooth muscle cell proliferation by nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2802%2900113-1

7 January 2021

Cyclins and cell cycle checkpoints

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2802%2900113-1

7 January 2021

Nitric oxide mediated venodilator effects of nebivolol

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2802%2900113-1

7 January 2021

The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2802%2900113-1

7 January 2021

Nitric oxide inhibits ornithine decarboxylase by S-nitrosylation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2802%2900113-1

7 January 2021

NG-methyl-L-arginine causes endothelium-dependent contraction and inhibition of cyclic GMP formation in artery and vein

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2802%2900113-1

7 January 2021

Induction of arginase II in human Caco-2 tumor cells by cyclic AMP.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2802%2900113-1

7 January 2021

Maternal dietary protein deficiency decreases nitric oxide synthase and ornithine decarboxylase activities in placenta and endometrium of pigs during early gestation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2802%2900113-1

7 January 2021

Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2802%2900113-1

7 January 2021

Microbial flora in the gastrointestinal tract abolishes cytostatic effects of alpha-difluoromethylornithine in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2802%2900113-1

7 January 2021

Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective beta 1-adrenergic antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2802%2900113-1

7 January 2021

Effects of D-Nebivolol and L-Nebivolol on Left Ventricular Systolic and Diastolic Function

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2802%2900113-1

7 January 2021

Pharmacological properties of nebivolol in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2802%2900113-1

7 January 2021

Nebivolol Induces Endothelium Dependent Relaxatíons of Canine Coronary Arteries

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2802%2900113-1

7 January 2021

Effects of vasodilatory beta-adrenoceptor antagonists on endothelium-derived nitric oxide release in rat kidney

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2802%2900113-1

7 January 2021

Nebivolol induces NO-mediated relaxations of rat small mesenteric but not of large elastic arteries

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2802%2900113-1

7 January 2021

Nebivolol inhibits human aortic smooth muscle cell growth: effects on cell cycle regulatory proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2802%2900113-1

7 January 2021

Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2802%2900113-1

7 January 2021

Effects of nebivolol on proliferation and apoptosis of human coronary artery smooth muscle and endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2802%2900113-1

7 January 2021

Role of polyamines in the control of cell proliferation and differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2802%2900113-1

7 January 2021

Polyamine metabolism and function

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2802%2900113-1

7 January 2021

"NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2802%2900113-1

7 January 2021

Effects of D-nebivolol and L-nebivolol on left ventricular systolic and diastolic function: comparison with D-L-nebivolol and atenolol.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S1089-8603(02)00113-1

Identifiers

DOI

10.1016/S1089-8603(02)00113-1

1 reference

30 November 2017

1 reference